The atrial natriuretic factor in hypertension. State of the art lecture.
Authors:
- 1 February 1988
- journal article
- review article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 11 (2_pt_2) , I3-7
Abstract
Studies were conducted to assess the effects of bolus injections and infusions of human atrial natriuretic factor (ANF) in control subjects and patients with mild essential hypertension, and to measure plasma immunoreactive ANF (irANF) concentration in a large group of patients with essential hypertension. The results are compared with those obtained by other groups on the measurements of plasma irANF in hypertensive patients. It appears that plasma irANF concentrations are not increased in patients with mild essential hypertension despite the evidence of increased preload and of atrial distention as reported by others. This suggests a hyporesponsiveness of the atria to release ANF.Keywords
This publication has 35 references indexed in Scilit:
- Atrial Natriuretic Peptide in Human Essential HypertensionMayo Clinic Proceedings, 1987
- Circulating atrial natriuretic polypeptide in essential hypertensionAmerican Heart Journal, 1987
- Atrial Natriuretic Peptide and Atrial PressureNew England Journal of Medicine, 1987
- Atrial Natriuretic Peptide and Atrial Pressure in Patients with Congestive Heart FailureNew England Journal of Medicine, 1986
- Concomitant increase in plasma atrial natriuretic peptide and cyclic GMP during volume loadingJournal of Molecular Medicine, 1985
- Demonstration and characterization of α‐human atrial natriuretic factor in human plasmaFEBS Letters, 1985
- Plasma levels of cyclic nucleotides in patients with essential hypertension.Japanese Heart Journal, 1980
- Right ventricular performance in essential hypertension.Circulation, 1980
- Cardiac load and function in hypertensionThe American Journal of Cardiology, 1979
- Pulmonary hemodynamics and right ventricular function in hypertension.Circulation, 1978